- Home
- ELDN vs JMSB Comparison
ELDN vs JMSB Comparison
Compare ELDN & JMSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- JMSB
- Stock Information
- Founded
- ELDN 2004
- JMSB 2005
- Country
- ELDN United States
- JMSB United States
- Employees
- ELDN N/A
- JMSB N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- JMSB Major Banks
- Sector
- ELDN Health Care
- JMSB Finance
- Exchange
- ELDN Nasdaq
- JMSB Nasdaq
- Market Cap
- ELDN 178.4M
- JMSB 268.9M
- IPO Year
- ELDN N/A
- JMSB N/A
- Fundamental
- Price
- ELDN $3.17
- JMSB $17.16
- Analyst Decision
- ELDN Strong Buy
- JMSB
- Analyst Count
- ELDN 1
- JMSB 0
- Target Price
- ELDN $16.00
- JMSB N/A
- AVG Volume (30 Days)
- ELDN 150.4K
- JMSB 23.0K
- Earning Date
- ELDN 05-20-2025
- JMSB 04-23-2025
- Dividend Yield
- ELDN N/A
- JMSB 2.94%
- EPS Growth
- ELDN N/A
- JMSB 472.90
- EPS
- ELDN N/A
- JMSB 1.24
- Revenue
- ELDN N/A
- JMSB $54,782,000.00
- Revenue This Year
- ELDN N/A
- JMSB N/A
- Revenue Next Year
- ELDN N/A
- JMSB N/A
- P/E Ratio
- ELDN N/A
- JMSB $13.69
- Revenue Growth
- ELDN N/A
- JMSB 50.81
- 52 Week Low
- ELDN $2.00
- JMSB $13.81
- 52 Week High
- ELDN $5.54
- JMSB $26.52
- Technical
- Relative Strength Index (RSI)
- ELDN 48.82
- JMSB 59.88
- Support Level
- ELDN $2.85
- JMSB $16.67
- Resistance Level
- ELDN $3.51
- JMSB $17.70
- Average True Range (ATR)
- ELDN 0.25
- JMSB 0.60
- MACD
- ELDN 0.01
- JMSB 0.25
- Stochastic Oscillator
- ELDN 45.07
- JMSB 82.46
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About JMSB John Marshall Bancorp Inc.
John Marshall Bancorp Inc provides banking services. The company offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.